The Pharmacy Times® Breast Cancer Resource Center is a comprehensive resource for clinical news and expert insights on issues related to cancers that occur in the breast, including invasive ductal carcinoma, invasive lobular carcinoma, and less common forms of the disease.
July 2nd 2025
Research reveals a link between estrogen plus progestin hormone therapy and increased breast cancer risk in young women, urging personalized treatment approaches.
Study: Statins May Protect the Heart from Chemotherapy Treatment of Early Breast Cancer
January 7th 2021According to the study authors, previous small studies suggested that women taking statins may have less heart muscle damage from these types of chemotherapy, yet the exact mechanisms of how statins protect against the cardiac cell damage remains unknown.
Read More
Socio-Economic Factors, Policy Changes Impact Disparities Among Breast Cancer Patients
December 10th 2020Session at at the San Antonio Breast Cancer Symposium featured several abstract presentations on disparities in health care access in breast cancer, including research on the necessity of avoiding a one-size-fits-all approach to medicine.
Read More
Impact of the COVID-19 Pandemic on Breast Cancer Treatment, Management Across the Country
December 9th 2020There were significant modifications in breast cancer treatment due to the coronavirus disease 2019 pandemic, such as high rates of NET chemotherapy, genomic assay testing on core biopsies, and delays in planned surgeries.
Read More
New Optical Method Could Enable Cancer Biomarker Breath Test
December 1st 2020The new optical sensing method is based on multi-pass spectroscopy and can detect the presence of 1 molecule of formaldehyde in a million air particles, or 1 part per million, even in the presence of gasses that often interfere with optical measurements.
Read More
Study: Black Women More Likely to Experience Delays in Breast Cancer Treatment
November 5th 2020Black women experience longer waiting periods before treatment is initiated than White women following a breast cancer diagnosis, as well as a prolonged treatment duration compared with White women.
Read More
FDA Approves FoundationOne Liquid CDx for Breast, Ovarian, Lung Cancer Indications
October 28th 2020FDA approves FoundationOne Liquid CDx as a companion diagnostic for alpelisib in advanced or metastatic breast cancer, rucaparib in advanced ovarian cancer, and alectinib in a specific type of metastatic non–small cell lung cancer.
Read More
Axillary Surgery May Not Be Required for All Women With Invasive Breast Cancer
October 27th 2020An axillary lymph node dissection, which is the surgical removal of 10 to 20 lymph nodes from the breast, is a procedure conducted in up to 25% of women with breast cancer to disable symptoms of arm swelling.
Read More